Healthcare / Medical Care FacilitiesASX
$6.51
-0.07 (-1.06%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 24% · confianza 25%
FCF escenarios
weak_data · normalized FCF $186.6M · quality 70.0/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
41/100
C
Piotroski
4/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$2.0B
P/E
54.3x
↑EV/EBITDA
7.4x
↓ROE
-292.7%
↓Gross Margin
100.0%
↑Debt/Equity
-0.31
↓TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
+77.6%
FCF CAGR
+49.2%
FCF margin
18.9%
FCF / Net income
4.49x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $1.16B · net income $49.0M · FCF $219.6M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $1.16B | $1.16B | $1.01B | $231.0M | $207.5M |
| Net Income | $49.0M | $49.0M | $-21.4M | $-28.5M | $-38.8M |
| EBITDA | $240.4M | $240.4M | $191.2M | $159.4M | $118.0M |
| EPS | 0.16 | 0.16 | -0.07 | -0.09 | -0.13 |
| Gross Margin | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| Operating Margin | 5.2% | 5.2% | -4.0% | -274.2% | -276.8% |
| Net Margin | 4.2% | 4.2% | -2.1% | -12.3% | -18.7% |
| Balance Sheet | |||||
| Debt/Equity | -0.31 | -0.31 | -0.17 | 3.60 | 1.43 |
| Current Ratio | 0.09 | 0.09 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $219.6M | $219.6M | $186.6M | $51.7M | $66.1M |
| Returns | |||||
| ROE | -292.7% | -292.7% | 93.6% | -74.1% | -49.1% |
| Valuation | |||||
| P/E | 54.25 | 54.25 | — | — | — |
| EV/EBITDA | 7.45 | 7.45 | 6.31 | 4.64 | 5.69 |
| P/B | — | — | — | 17.24 | 7.12 |
| Growth & Yield | |||||
| Revenue Growth | 14.5% | 14.5% | 339.0% | 11.3% | — |
| EPS Growth | 326.6% | 326.6% | 24.8% | 26.7% | — |
| Dividend Yield | 2.8% | 2.8% | — | — | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
53.1%
EPS terminal req.
$0.58
Spread vs growth
273.5%
5Y implied EPS CAGR
34.1%
EPS terminal req.
$0.70
Spread vs growth
292.5%
10Y implied EPS CAGR
21.5%
EPS terminal req.
$1.13
Spread vs growth
305.1%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
-15.6%
Start / end P/E
n/dx → n/dx
EPS bridge
-0.07 → 0.16
Residual
-18.3%
EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.